MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity
Article
[키워드] activated
Activation
acute phase
Admission
Analysis
ATM
Autoimmune
Autoimmune disease
Autoimmune diseases
autoimmune pathogenesis
autoinflammatory disease
Autoinflammatory diseases
B cell
cellular
Characteristics
children
clearance
complication of COVID-19
contribute
Critical
cytokine response
Cytokine storm
Cytokines
Cytometry
demonstrated
develop
diagnostic biomarker
DOCK8
event
FCN3
Flow
flow cytometry
Genetic
Genetic variant
healthy control
help
heterogeneity
Hospital admission
identified variant
IFN
IFN-α
IFN-β
IFN-γ
IFNγ
IL-10
IL-12p70
IL-17A
IL-6
immune dysregulation
immunodeficiency
immunological
induce
Inflammatory
inflammatory pathway
involved
knowledge
lymphocyte
lymphopenia
management
MCM4
MIS-C
MOST
multisystemic
mutated
NCF1
NGS
NOD2
organ
Pathogenesis
pathway
Patient
patients
Population
PRF1
reduction
serum
serum cytokine
significant increase
syndrome
Th1
the disease
therapeutic
Therapies
tissue damage
TNF
Type
variant
was increased
[DOI] 10.3389/fimmu.2022.985433 PMC 바로가기
[DOI] 10.3389/fimmu.2022.985433 PMC 바로가기